467 related articles for article (PubMed ID: 15159183)
21. Prostate cancer in Saudi Arabia in 2002.
Mosli HA
Saudi Med J; 2003 Jun; 24(6):573-81. PubMed ID: 12847583
[TBL] [Abstract][Full Text] [Related]
22. [Prevention practices and cancer screening among general practitioners in Picardy (France)].
Ganry O; Boche T
Bull Cancer; 2004 Oct; 91(10):785-91. PubMed ID: 15556879
[TBL] [Abstract][Full Text] [Related]
23. Comparison of the incidence of latent prostate cancer detected at autopsy before and after the prostate specific antigen era.
Konety BR; Bird VY; Deorah S; Dahmoush L
J Urol; 2005 Nov; 174(5):1785-8; discussion 1788. PubMed ID: 16217287
[TBL] [Abstract][Full Text] [Related]
24. Clinical characteristics and primary treatment of prostate cancer in Sweden between 1996 and 2005.
Adolfsson J; Garmo H; Varenhorst E; Ahlgren G; Ahlstrand C; Andrén O; Bill-Axelson A; Bratt O; Damber JE; Hellström K; Hellström M; Holmberg E; Holmberg L; Hugosson J; Johansson JE; Petterson B; Törnblom M; Widmark A; Stattin P
Scand J Urol Nephrol; 2007; 41(6):456-77. PubMed ID: 17934985
[TBL] [Abstract][Full Text] [Related]
25. Association of colorectal cancer and prostate cancer and impact of radiation therapy.
Huo D; Hetzel JT; Roy H; Rubin DT
Cancer Epidemiol Biomarkers Prev; 2009 Jul; 18(7):1979-85. PubMed ID: 19531678
[TBL] [Abstract][Full Text] [Related]
26. Interval cancers in prostate cancer screening: comparing 2- and 4-year screening intervals in the European Randomized Study of Screening for Prostate Cancer, Gothenburg and Rotterdam.
Roobol MJ; Grenabo A; Schröder FH; Hugosson J
J Natl Cancer Inst; 2007 Sep; 99(17):1296-303. PubMed ID: 17728218
[TBL] [Abstract][Full Text] [Related]
27. The cancer survival gap between elderly and middle-aged patients in Europe is widening.
Quaglia A; Tavilla A; Shack L; Brenner H; Janssen-Heijnen M; Allemani C; Colonna M; Grande E; Grosclaude P; Vercelli M;
Eur J Cancer; 2009 Apr; 45(6):1006-16. PubMed ID: 19121578
[TBL] [Abstract][Full Text] [Related]
28. Incidence of initial local therapy among men with lower-risk prostate cancer in the United States.
Miller DC; Gruber SB; Hollenbeck BK; Montie JE; Wei JT
J Natl Cancer Inst; 2006 Aug; 98(16):1134-41. PubMed ID: 16912266
[TBL] [Abstract][Full Text] [Related]
29. Trends in area-socioeconomic and race-ethnic disparities in breast cancer incidence, stage at diagnosis, screening, mortality, and survival among women ages 50 years and over (1987-2005).
Harper S; Lynch J; Meersman SC; Breen N; Davis WW; Reichman MC
Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):121-31. PubMed ID: 19124489
[TBL] [Abstract][Full Text] [Related]
30. The epidemiology of prostate cancer part I: descriptive epidemiology.
Brawley OW; Knopf K; Merrill R
Semin Urol Oncol; 1998 Nov; 16(4):187-92. PubMed ID: 9858324
[TBL] [Abstract][Full Text] [Related]
31. Geographic patterns of prostate cancer mortality and variations in access to medical care in the United States.
Jemal A; Ward E; Wu X; Martin HJ; McLaughlin CC; Thun MJ
Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):590-5. PubMed ID: 15767335
[TBL] [Abstract][Full Text] [Related]
32. Breast, colon, and prostate screening in the adult population of Croatia: does rural origin matter?
Polasek O; Kolcic I; Voncina L; Strnad M; Vuletic S; Kern J
Rural Remote Health; 2007; 7(3):749. PubMed ID: 17900222
[TBL] [Abstract][Full Text] [Related]
33. Association of insurance with cancer care utilization and outcomes.
Ward E; Halpern M; Schrag N; Cokkinides V; DeSantis C; Bandi P; Siegel R; Stewart A; Jemal A
CA Cancer J Clin; 2008; 58(1):9-31. PubMed ID: 18096863
[TBL] [Abstract][Full Text] [Related]
34. Prostate cancer outcomes among older men: insurance status comparisons results from CaPSURE database.
Sadetsky N; Elkin EP; Latini DM; DuChane J; Carroll PR;
Prostate Cancer Prostatic Dis; 2008; 11(3):280-7. PubMed ID: 17893700
[TBL] [Abstract][Full Text] [Related]
35. Changes in case mix and treatment patterns in prostate cancer in Saskatchewan during the prostate specific antigen testing era.
Tonita JM; Skarsgard D; Muhajarine N
Cancer Causes Control; 2009 Mar; 20(2):201-9. PubMed ID: 18825504
[TBL] [Abstract][Full Text] [Related]
36. Prevalence of prostate cancer in aging males receiving PSA (prostate specific antigen) screening test (A campaign for celebration of Siriraj Established Day).
Srinualnad S; Charoenkraikamol C; Toraksa S; Uiprasertkul M; Amornvesukit T; Taweemonkongsap T; Udompunturak S; Nualyong C; Tantiwong A
J Med Assoc Thai; 2006 Jan; 89(1):37-42. PubMed ID: 16583579
[TBL] [Abstract][Full Text] [Related]
37. Interpreting trends in prostate cancer incidence and mortality in the five Nordic countries.
Kvåle R; Auvinen A; Adami HO; Klint A; Hernes E; Møller B; Pukkala E; Storm HH; Tryggvadottir L; Tretli S; Wahlqvist R; Weiderpass E; Bray F
J Natl Cancer Inst; 2007 Dec; 99(24):1881-7. PubMed ID: 18073376
[TBL] [Abstract][Full Text] [Related]
38. Chemoprevention strategies for prostate cancer.
Bosland MC; McCormick DL; Melamed J; Walden PD; Zeleniuch-Jacquotte A; Lumey LH
Eur J Cancer Prev; 2002 Aug; 11 Suppl 2():S18-27. PubMed ID: 12570331
[TBL] [Abstract][Full Text] [Related]
39. A model of prostate-specific antigen screening outcomes for low- to high-risk men: information to support informed choices.
Howard K; Barratt A; Mann GJ; Patel MI
Arch Intern Med; 2009 Sep; 169(17):1603-10. PubMed ID: 19786680
[TBL] [Abstract][Full Text] [Related]
40. Prostate cancer.
Penson DF; Chan JM;
J Urol; 2007 Jun; 177(6):2020-9. PubMed ID: 17509282
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
